Abingworth LLP
Insider CIK 1397144 · SRRA 10% owner · CHMA 10% owner · PRTO 10% owner · SLNO 10% owner · PSNL 10% owner · SIEN 10% owner · PCVX 10% owner · JSPR 10% owner · EFTR 10% owner · VERA 10% owner · AMRN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JSPR Jasper Therapeutics, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 190,000 | $12.95 | $2.46M | 1,066,189 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | C Conversion deriv | 2023-09-28 | 2023-10-02 | 762,126 | $1.75 | $1.33M | 762,126 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | C Conversion deriv | 2023-09-28 | 2023-10-02 | 1,092,056 | — | $0 | 0 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | C Conversion | 2023-09-28 | 2023-10-02 | 329,930 | $1.75 | $577.4K | 1,531,436 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy deriv | 2023-05-08 | 2023-05-10 | 1,778,000 | $0.44 | $782.3K | 1,778,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy deriv | 2023-05-08 | 2023-05-10 | 1,092,056 | $0.44 | $480.5K | 1,092,056 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | P Buy | 2023-01-27 | 2023-01-31 | 3,133,333 | $1.50 | $4.70M | 8,761,891 | SEC↗ |
| VERA Vera Therapeutics, Inc. | M Exercise deriv | 2022-08-17 | 2022-08-19 | 9,925 | — | $0 | 0 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2022-08-17 | 2022-08-19 | 172 | $21.07 | $3.6K | 2,960,231 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2022-08-17 | 2022-08-19 | 6,472 | $20.42 | $132.2K | 2,960,403 | SEC↗ |
| VERA Vera Therapeutics, Inc. | S Sale | 2022-08-17 | 2022-08-19 | 3,281 | $19.88 | $65.2K | 2,966,875 | SEC↗ |
| VERA Vera Therapeutics, Inc. | M Exercise | 2022-08-17 | 2022-08-19 | 9,925 | $11.00 | $109.2K | 2,970,156 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy deriv | 2022-03-29 | 2022-03-31 | 7,720,000 | — | $0 | 7,720,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2022-03-29 | 2022-03-31 | 7,720,000 | — | $0 | 18,022,602 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2022-03-21 | 2022-03-23 | 78,045 | — | $0 | 78,045 | SEC↗ |
| SRRA Sierra Oncology, Inc. | P Buy | 2022-01-31 | 2022-02-01 | 150,000 | $27.00 | $4.05M | 1,314,127 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-28 | 2022-02-01 | 287,471 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-28 | 2022-02-01 | 287,471 | $13.20 | $3.79M | 1,164,127 | SEC↗ |
| EFTR eFFECTOR Therapeutics, Inc | A Award deriv | 2021-10-06 | 2021-12-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2021-06-01 | 2022-03-31 | 31,862 | — | $0 | 31,862 | SEC↗ |
| VERA Vera Therapeutics, Inc. | C Conversion | 2021-05-18 | 2021-05-18 | 2,187,504 | — | $0 | 2,187,504 | SEC↗ |
| VERA Vera Therapeutics, Inc. | P Buy | 2021-05-18 | 2021-05-18 | 772,727 | $11.00 | $8.50M | 2,960,231 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2021-05-13 | 2021-05-18 | 9,925 | — | $0 | 9,925 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2021-01-08 | 2022-03-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PSNL Personalis, Inc. | S Sale | 2020-10-20 | 2020-10-21 | 130,486 | $27.66 | $3.61M | 3,753,340 | SEC↗ |
| PSNL Personalis, Inc. | S Sale | 2020-10-19 | 2020-10-20 | 196,423 | $27.86 | $5.47M | 3,883,826 | SEC↗ |
| PSNL Personalis, Inc. | S Sale | 2020-10-16 | 2020-10-20 | 94,218 | $26.68 | $2.51M | 4,080,249 | SEC↗ |
| PSNL Personalis, Inc. | S Sale | 2020-10-15 | 2020-10-16 | 3,700 | $26.32 | $97.4K | 4,174,467 | SEC↗ |
| PSNL Personalis, Inc. | S Sale | 2020-10-14 | 2020-10-16 | 81,925 | $27.08 | $2.22M | 4,178,167 | SEC↗ |
| PSNL Personalis, Inc. | S Sale | 2020-10-13 | 2020-10-14 | 86,819 | $28.43 | $2.47M | 4,260,092 | SEC↗ |
| PSNL Personalis, Inc. | S Sale | 2020-10-12 | 2020-10-14 | 115,541 | $29.09 | $3.36M | 4,346,911 | SEC↗ |
| PSNL Personalis, Inc. | S Sale | 2020-08-18 | 2020-08-20 | 986,842 | $19.00 | $18.75M | 4,462,452 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2020-06-26 | 2020-07-06 | 3,333,330 | $1.65 | $5.50M | 10,302,602 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| PCVX Vaxcyte, Inc. | A Award deriv | 2020-06-11 | 2020-06-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2020-05-18 | 2022-03-31 | 9,530 | — | $0 | 9,530 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2019-11-12 | 2019-11-14 | 126 | — | $0 | 2,400 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2019-11-12 | 2019-11-14 | 126,645 | $0.99 | $125.4K | 2,144,517 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2019-10-25 | 2019-10-29 | 2,300,000 | $1.20 | $2.76M | 6,969,272 | SEC↗ |
| PSNL Personalis, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-26 | 2,317,073 | — | $0 | 0 | SEC↗ |
| PSNL Personalis, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-26 | 2,065,217 | — | $0 | 0 | SEC↗ |
| PSNL Personalis, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-26 | 878,361 | — | $0 | 0 | SEC↗ |
| PSNL Personalis, Inc. | C Conversion | 2019-06-24 | 2019-06-26 | 878,361 | — | $0 | 5,449,294 | SEC↗ |
| PSNL Personalis, Inc. | C Conversion | 2019-06-24 | 2019-06-26 | 2,317,073 | — | $0 | 2,505,716 | SEC↗ |
| PSNL Personalis, Inc. | C Conversion | 2019-06-24 | 2019-06-26 | 2,065,217 | — | $0 | 4,570,933 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2019-06-10 | 2022-03-31 | 13,000 | — | $0 | 13,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2018-12-21 | 2022-03-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2018-06-08 | 2018-06-11 | 12,700 | — | $0 | 12,700 | SEC↗ |
| SIEN Sientra, Inc. | P Buy | 2018-05-07 | 2018-05-09 | 281,482 | $13.50 | $3.80M | 2,480,494 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy deriv | 2017-06-22 | 2017-06-26 | 2,526 | $1000.00 | $2.53M | 2,526 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2017-06-20 | 2017-06-21 | 6,666 | — | $0 | 6,666 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | A Award deriv | 2016-06-09 | 2016-06-14 | 6,666 | — | $0 | 6,666 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion deriv | 2015-07-15 | 2016-03-09 | 1,642,575 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | J Other deriv | 2015-07-15 | 2016-03-09 | 109,504 | — | $0 | 109,504 | SEC↗ |
| CHMA CHIASMA, INC | J Other deriv | 2015-07-15 | 2016-03-09 | 410,642 | — | $0 | 410,642 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion deriv | 2015-07-15 | 2016-03-09 | 438,020 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion | 2015-07-15 | 2016-03-09 | 2,080,595 | — | $0 | 2,080,595 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion deriv | 2015-07-15 | 2015-07-17 | 109,504 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion deriv | 2015-07-15 | 2015-07-17 | 410,642 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion deriv | 2015-07-15 | 2015-07-17 | 1,642,575 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion deriv | 2015-07-15 | 2015-07-17 | 438,020 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | C Conversion | 2015-07-15 | 2015-07-17 | 2,600,741 | — | $0 | 2,600,741 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | J Other deriv | 2015-06-02 | 2015-06-03 | 6,666 | — | $0 | 6,666 | SEC↗ |
| SIEN Sientra, Inc. | P Buy | 2014-10-29 | 2014-10-31 | 495,000 | $15.00 | $7.42M | 2,199,012 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | J Other deriv | 2014-10-27 | 2014-10-29 | 12,835,264 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion deriv | 2014-10-27 | 2014-10-29 | 16,044,081 | — | $0 | 0 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | C Conversion | 2014-10-27 | 2014-10-29 | 1,067,872 | — | $0 | 2,017,872 | SEC↗ |
| PRTO PROTEON THERAPEUTICS INC | P Buy | 2014-10-27 | 2014-10-29 | 950,000 | $10.00 | $9.50M | 950,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-04-19 | 2012-04-19 | 682,000 | $9.66 | $6.59M | 1,599,168 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-04-19 | 2012-04-26 | 682,000 | $9.66 | $6.59M | 1,599,168 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-04-18 | 2012-04-19 | 1,614,341 | $9.60 | $15.50M | 2,281,168 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-04-18 | 2012-04-26 | 1,614,341 | $9.60 | $15.50M | 2,281,168 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-04-17 | 2012-04-19 | 1,712,000 | $9.61 | $16.45M | 3,895,509 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-04-17 | 2012-04-26 | 1,712,000 | $9.61 | $16.45M | 3,895,509 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2012-04-03 | 2012-04-05 | 2,300,000 | $11.00 | $25.30M | 5,607,509 | SEC↗ |